Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

CAS No. :	100427-26-7
Formula :	C₃₆H₄₁N₃O₆
M.W :	611.73
SMILES Code :	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OC(C)(C)CN(CCC(C3=CC=CC=C3)C4=CC=CC=C4)C
MDL No. :	MFCD00867978

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H301
Precautionary Statements:	P264-P270-P301+P310+P330-P405-P501
Class:	6.1
UN#:	2811
Packing Group:	Ⅲ

Vero cells	10 μM	1 h	Screening for LUJV entry inhibitors	Front Microbiol. 2021 Dec 2;12:793519.
Chang (normal liver cells)	10 μM	24 h	Lercanidipine did not significantly increase the cytotoxicity of Bortezomib in normal cells	Int J Mol Sci. 2019 Dec 4;20(24):6112.
MCF-10A (normal breast cells)	10 μM	24 h	Lercanidipine did not significantly increase the cytotoxicity of Bortezomib in normal cells	Int J Mol Sci. 2019 Dec 4;20(24):6112.
RPMI-8226 (multiple myeloma cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
BxPC-3 (pancreatic cancer cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
NCI-H460 (lung cancer cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
SNU-668 (stomach cancer cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
SNU-475 (liver cancer cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
MDA-MB 435S (breast cancer cells)	10 μM	24 h	Lercanidipine enhances the cytotoxicity of Bortezomib in cancer cells, inducing paraptosis-associated cell death	Int J Mol Sci. 2019 Dec 4;20(24):6112.
Primary lung cancer cells	10 μM	24 h	Inhibited the expression of PD-L1	Front Pharmacol. 2021 Jan 13;11:539261.
NCI-H460 cells	10 μM	24 h	Inhibited the transcriptional levels of PD-L1	Front Pharmacol. 2021 Jan 13;11:539261.
NCI-H1299 cells	10 μM	24 h	Inhibited the transcriptional levels of PD-L1	Front Pharmacol. 2021 Jan 13;11:539261.
A172GSC cells	7 μM		Inhibited GLT8D1 expression, reduced CD133 and β-catenin protein stability	Cell Death Differ. 2022 Sep;29(9):1834-1849.
U251GSC cells	7 μM		Inhibited GLT8D1 expression, reduced CD133 and β-catenin protein stability	Cell Death Differ. 2022 Sep;29(9):1834-1849.
GBM1 cells	7 μM		Inhibited GLT8D1 expression, reduced CD133 and β-catenin protein stability	Cell Death Differ. 2022 Sep;29(9):1834-1849.
GSC11 cells	7 μM		Inhibited GLT8D1 expression, reduced CD133 and β-catenin protein stability	Cell Death Differ. 2022 Sep;29(9):1834-1849.
OC-1 cells	0.3 to 2.5 µM	24 h	To evaluate the antioxidative effect of Lercanidipine on OC-1 cell viability, results showed that 0.3 to 2.5 µM Lercanidipine significantly enhanced cellular viability	Antioxidants (Basel). 2024 Mar 7;13(3):327.
CHO cells (expressing Ca v1.2b subunit)	10^-7 M	600 s	To study the inhibitory effect of (S)-lercanidipine on vascular Ca v1.2b subunit, showing IC50=1.8×10^-8 M, Hill coefficient nH=0.8, indicating higher selectivity for the vascular isoform.	Br J Pharmacol. 2004 May;142(2):275-84.
CHO cells (expressing Ca v1.2a subunit)	10^-7 M	600 s	To study the inhibitory effect of (S)-lercanidipine on cardiac Ca v1.2a subunit, showing IC50=3.3×10^-8 M, Hill coefficient nH=2.3, indicating overlap between agonistic and antagonistic effects.	Br J Pharmacol. 2004 May;142(2):275-84.

Nude mice	Xenograft tumor models	Tail vein injection	5 mg/kg	Twice every week for four weeks	Suppressed tumor growth, reduced GLT8D1 and CD133 expression, increased apoptosis markers	Cell Death Differ. 2022 Sep;29(9):1834-1849.
White New Zealand rabbits	Atherosclerotic lesions induced by cholesterol feeding	Subcutaneous injection	0.3, 1, and 3 mg/kg	Once a week for 10 weeks	Significantly reduced intimal hyperplasia and aortic fatty streak area in a dose-dependent manner	Br J Pharmacol. 1998 Dec;125(7):1471-6
C57BL/6J mice	Noise-induced hearing loss model	Intraperitoneal injection	6 mg/kg	1 hour before noise exposure and once daily on days 1, 2, and 3 post-exposure	To investigate the protective effect of Lercanidipine against noise-induced hearing loss, results showed that Lercanidipine significantly attenuated the elevation of hearing thresholds and preserved OHC survival in the basal turn	Antioxidants (Basel). 2024 Mar 7;13(3):327.

{[proInfo.proName]}

CAS No.: 100427-26-7

{[proInfo.proName]}

CAS No.: 100427-26-7

Alternative Products

Product Details of Lercanidipine

Safety of Lercanidipine

Related Pathways of Lercanidipine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00424801	Microvascular Angina ... More >> Hypertension Less <<	Not Applicable	Terminated(Due to recent findi... More >>ngs relating MRI contrast to nephrogenic systemic fibrosis) Less <<	December 2008	Denmark ... More >> Aarhus Hospital Aarhus, Denmark, 8000 Less <<
NCT00741585	Essential Hypertension ... More >> Cardiovascular Disease Stroke Chronic Kidney Disease Less <<	Phase 4	Completed	-	Spain ... More >> CS Friol Friol, Lugo, Spain, 27220 CS Baiona Baiona, Pontevedra, Spain, 36300 CS Bueu Bueu, Pontevedra, Spain, 36930 CS A Estrada La Estrada, Pontevedra, Spain, 26680 CS A Guarda La Guardia, Pontevedra, Spain, 36780 CS Valmiñor Nigran, Pontevedra, Spain, 36250 CS Panxón Nigrán, Pontevedra, Spain, 36340 CS Tomiño Tomiño, Pontevedra, Spain, 36200 Bioengineering & Chronobilogy Labs., University of Vigo Vigo, Pontevedra, Spain, 36200 Hospital do Meixoeiro Vigo, Pontevedra, Spain, 36200 CS Calle Cuba Vigo, Pontevedra, Spain, 36202 CS A Doblada Vigo, Pontevedra, Spain, 36205 CS Coia Vigo, Pontevedra, Spain, 36209 CS Sardoma Vigo, Pontevedra, Spain, 36214 CS Teis Vigo, Pontevedra, Spain, 36216 CS Vilaboa Vilaboa, Pontevedra, Spain, 36141 CS San Roque Vilagarcía De Arousa, Pontevedra, Spain, 36600 CS Fingoi Lugo, Spain, 27002 Complexo Hospitalario Universitario de Ourense Orense, Spain, 32005 CS Lerez Pontevedra, Spain, 36156 Less <<
NCT02594410	Hypertension	Phase 4	Completed	-	China ... More >> Fuwai Hospital Beijing, China Less <<
NCT02415192	-		Unknown	November 2016	Korea, Republic of ... More >> LG Life Science Recruiting Seoul, Jongno gu, Korea, Republic of, 110-783 Contact: Hye jin Yoon Less <<
NCT03195023	Renal Insufficiency, Chronic ... More >> Proteinuria Less <<	Phase 4	Recruiting	June 2021	Spain ... More >> Gregorio Maranon Hospital Recruiting Madrid, Spain, 28007 Contact: Maria Angeles Goicoechea, PhD, MD 0034609838684 marian.goicoechea@gmail.com Contact: Ana María García, MD 0034676611045 anamgarciaprieto@gmail.com Less <<
NCT01211314	Hypertension	Phase 4	Terminated(sponsor decision)	-	Israel ... More >> Clalit Health Services Hertsliyah, Hasharon, Israel Less <<
NCT01180413	Essential Hypertension ... More >> High Blood Pressure Less <<	Phase 4	Completed	-	Denmark ... More >> Aarhus University Hospital - dept. cardiology (A) Aarhus, Denmark, 8000 Less <<
NCT01093807	Essential Hypertension	Phase 2	Completed	-	France ... More >> Hôpital de la Pitié-Salpétrière Paris, France Less <<
NCT00160498	Hypertension		COMPLETED	2025-08-05	-
NCT01928628	Hypertension	Phase 3	Completed	-	Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01122251	Essential Hypertension	Phase 2	Completed	-	Korea, Republic of ... More >> 23 sites in Korea Seoul, Busan etc., Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01520285	Hypertension	Phase 4	Completed	-	China ... More >> Shanghai First People's Hospital Shanghai, China, 200000 Less <<
NCT03497156	Obesity, Morbid		RECRUITING	2025-10-26	St. Olavs University Hospital,... More >> Trondheim, Norway Less <<
NCT00564057	HIV Infections ... More >> Hypertension Less <<	Phase 4	Unknown	September 2009	Italy ... More >> University of Insubria, Department of Clinical Medicine Recruiting Varese, Italy, 21100 Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed